Table 2.
Men
|
Women
|
|||||||
---|---|---|---|---|---|---|---|---|
CT-derived measures | Model | Sleep hours | B | 95% CI | p-value | B | 95% CI | p-value |
Thigh muscle lean area, cm2 | 1 | <6h | 0.70 | −2.14, 3.53 | 0.63 | −0.01 | −1.54, 1.53 | 0.99 |
>8h | −4.07 | −6.49, −1.66 | 0.001 | −2.50 | −4.37, −0.62 | 0.009 | ||
2 | <6h | −0.20 | −2.39, 1.99 | 0.86 | 0.13 | −1.01, 1.26 | 0.83 | |
>8h | −2.21 | −4.01, −0.40 | 0.017 | −2.39 | −3.75, −1.03 | 0.001 | ||
3 | <6h | 0.79 | −1.27, 2.85 | 0.45 | 0.27 | −0.82, 1.37 | 0.62 | |
>8h | −0.22 | −1.95, 1.50 | 0.80 | −1.15 | −2.49, 0.19 | 0.09 | ||
Thigh muscle attenuation, HU | 1 | <6h | −0.66 | −1.39, 0.07 | 0.078 | −0.27 | −0.78, 0.24 | 0.30 |
>8h | −1.27 | −1.87, −0.66 | <0.001 | −1.56 | −2.13, −0.98 | <0.001 | ||
2 | <6h | −0.49 | −1.13, 0.15 | 0.14 | −0.17 | −0.62, 0.28 | 0.47 | |
>8h | −0.48 | −1.02, 0.06 | 0.08 | −0.95 | −1.47, −0.43 | <0.001 | ||
3 | <6h | −0.27 | −0.89, 0.35 | 0.39 | −0.11 | −0.55, 0.33 | 0.61 | |
>8h | −0.08 | −0.61, 0.46 | 0.78 | −0.51 | −1.03, −0.002 | 0.049 | ||
Total hip integral vBMD, mg/cm3 | 1 | <6h | 4.23 | −2.57, 11.03 | 0.22 | −0.69 | −5.15, 3.77 | 0.76 |
>8h | −5.24 | −10.79, 0.32 | 0.07 | −5.73 | −11.32, −0.14 | 0.045 | ||
2 | <6h | 3.41 | −3.10, 9.91 | 0.30 | −0.15 | −4.21, 3.92 | 0.94 | |
>8h | −3.02 | −8.39, 2.36 | 0.27 | −3.87 | −8.97, 1.23 | 0.14 | ||
3 | <6h | 4.23 | −2.23, 10.69 | 0.20 | −0.06 | −4.07, 3.94 | 0.98 | |
>8h | −1.39 | −6.90, 4.12 | 0.62 | −1.57 | −6.68, 3.55 | 0.55 |
Reference category: 6–8h of sleep per 24-hour period; Model 1: unadjusted model; Model 2: adjusted for age and BMI; Model 3: further adjusted for physical activity level, smoking status, health status, mobility disability status, number of medical conditions, cognitive status, hs-CRP, 25OHD and bone medication (only in the vBMD predictor model).